Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)
Jacques Bernier(Ospedale San Giovanni Bellinzona), Jean Louis Lefèbvre(Centre Oscar Lambret), Jay S. Cooper(Columbia University Irving Medical Center), Thomas F. Pajak(American College of Radiology), Jean Bourhis(University of Lausanne), John R. Jacobs(University of Washington Medical Center), M. van Glabbeke(Institut Jules Bordet), Kie-Kian Ang(Radiation Oncology Associates), Jacek Jassem(Gdańsk Medical University), Esat Mahmut Özşahin(University of Lausanne), Arlene A. Forastiere(Greater Baltimore Medical Center)
Cited by 1,767
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
|The Lancet|2002|1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
|New England Journal of Medicine|1997|1.6k